A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT 04771130 Brief Summary The study will determine the safety, tolerability, recommended…
Read more arrow_forwardNCT 04771130 Brief Summary The study will determine the safety, tolerability, recommended…
Read more arrow_forwardNCT 06456463 Brief Summary This study will be divided into 2 parts…
Read more arrow_forwardNCT 06508489 Brief Summary This is a parallel, Phase 1/Phase 2, randomized,…
Read more arrow_forwardNCT 05086315 Brief Summary This is an open-label, multicenter, Phase 1/Phase 2,…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 04262466 Brief Summary Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forwardNCT 04581512 Brief Summary A research study looking at a new treatment…
Read more arrow_forwardNCT 05756322 Brief Summary The most common types of acute leukaemia are…
Read more arrow_forward